74150-27-9

  • Product NamePimobendan
  • Molecular FormulaC19H18N4O2
  • Molecular Weight334.378
  • Purity99%
Inquiry

Product Details

Quick Details

  • CasNo: 74150-27-9
  • Molecular Formula: C19H18N4O2
  • Purity: 99%

Factory supply Pimobendan 74150-27-9 with sufficient stock and high standard

  • Molecular Formula:C19H18N4O2
  • Molecular Weight:334.378
  • Melting Point:approximate 243℃ (dec.) 
  • Refractive Index:1.692 
  • PKA:10.55±0.10(Predicted) 
  • PSA:79.37000 
  • Density:1.36 g/cm3 
  • LogP:2.86300 

Pimobendan(Cas 74150-27-9) Usage

Biological Activity

Pimobendan is an inhibitor of phosphodiesterase 3 (PDE3; IC50 = 0.32 μM for guinea pig cardiac enzyme) that is selective for PDE3 over PDE1, PDE2, and PDE4 (IC50s = >30 μM). It is also a calcium sensitizer, decreasing the concentration of calcium required for half-maximal contractile force in isolated, skinned porcine ventricular fibers. Pimobendan increases the force of contraction in electrically-stimulated isolated guinea pig papillary muscles with an EC50 value of 6 μM, indicating positive inotropic effects. It increases survival time in dogs with congestive heart failure due to myxomatous mitral valve disease when administered in combination with angiotensin-converting enzyme inhibitors and furosemide . Formulations containing pimobendan have been used in the treatment of heart failure in dogs.

Biochem/physiol Actions

Pimobendan is an inotropic agent with a dual mechanism of action: it increases myocardial contractility by increasing calcium sensitization to troponin C and it promotes vasodilation by inhibiting phosphodiesterase III (PDE3). Pimobendan has been studied for treating heart failure and cardiomyopathy, primarily for veterinary uses.

Veterinary Drugs and Treatments

Pimobendan is used to treat dogs with congestive heart failure secondary to dilated cardiomyopathy or chronic mitral valve insufficiency (CMVI).

Definition

ChEBI: Pimobendan is a pyridazinone and a member of benzimidazoles. It has a role as a cardiotonic drug, a vasodilator agent and an EC 3.1.4.* (phosphoric diester hydrolase) inhibitor.

Brand name

Acardl

InChI:InChI=1/C19H18N4O2/c1-11-9-16(22-23-19(11)24)13-5-8-15-17(10-13)21-18(20-15)12-3-6-14(25-2)7-4-12/h3-8,10-11H,9H2,1-2H3,(H,20,21)(H,23,24)/t11-/m1/s1

74150-27-9 Relevant articles

Preparation method of pimobendan

-

Paragraph 0015; 0022-0023, (2021/10/11)

The invention relates to a novel prepara...

Synthesis method of pimobendan

-

, (2020/08/29)

The invention provides a synthesis metho...

Novel method for preparing pimobendan from by-product for synthesizing pimobendan

-

Paragraph 0009; 0010; 0011, (2019/01/08)

The invention discloses a novel method f...

Chemical synthesis method of Pimobendan

-

, (2017/05/23)

The invention discloses a chemical synth...

74150-27-9 Process route

(5RS)-6-[1-(4-methoxybenzyl)-2-(4-methoxyphenyl)-1H-benzimidazole-6-yl]-5-methyl-4,5-dihydro-3(2H)pyridazinone

(5RS)-6-[1-(4-methoxybenzyl)-2-(4-methoxyphenyl)-1H-benzimidazole-6-yl]-5-methyl-4,5-dihydro-3(2H)pyridazinone

pimobendan
118428-37-8,118428-38-9,74150-27-9

pimobendan

Conditions
Conditions Yield
With ammonium cerium (IV) nitrate; In water; acetone; at 20 ℃; for 3h; Temperature;
91%
6-(2-bromo-1H-benzo[d]imidazol-6-yl)-5-methyl-4,5-dihydropyridazin-3(2H)-one

6-(2-bromo-1H-benzo[d]imidazol-6-yl)-5-methyl-4,5-dihydropyridazin-3(2H)-one

2-(4-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
171364-79-7

2-(4-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

pimobendan
118428-37-8,118428-38-9,74150-27-9

pimobendan

Conditions
Conditions Yield
6-(2-bromo-1H-benzo[d]imidazol-6-yl)-5-methyl-4,5-dihydropyridazin-3(2H)-one; With caesium carbonate; In 1,4-dioxane; N,N-dimethyl-formamide; at 20 ℃; for 1h; Inert atmosphere;
2-(4-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane; With bis-triphenylphosphine-palladium(II) chloride; In 1,4-dioxane; N,N-dimethyl-formamide; at 80 - 85 ℃; for 12h; Inert atmosphere;
84.9%

74150-27-9 Upstream products

  • 104-88-1
    104-88-1

    4-chlorobenzaldehyde

  • 117397-88-3
    117397-88-3

    6-(4-chloro-3-nitrophenyl)-5-methyl-2,3,4,5-tetrahydropyridazin-3-one

  • 123-11-5
    123-11-5

    4-methoxy-benzaldehyde

  • 136609-85-3
    136609-85-3

    6-(3,4-diaminophenyl)-5-methyl-2,3,4,5-tetrahydropyridazin-3-one

74150-27-9 Downstream products

  • 610769-04-5
    610769-04-5

    4,5-dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-3(2H)-pyridazinone hydrochloride

;
*Product Name
CasNo
Quantity
Company Name
Phone
*Email
*Description
*Code
Items marked with * are mandatory
Submit